You just read:

Regen BioPharma's Chief Scientific Officer Harry Lander Provides Clarity on the Process of Small Molecule Development for Cancer and Autoimmune Diseases

News provided by

Regen BioPharma, Inc.

Nov 16, 2016, 08:00 ET